Members of the family who own OxyContin maker Purdue Pharma, and the company itself, agreed to pay up to $7.4 billion in a new settlement to lawsuits over the toll of the powerful prescription ...
Members of the family who own OxyContin maker Purdue Pharma, and the company itself, agreed to pay up to $7.4 billion in a new settlement to lawsuits over the toll of the powerful prescription ...
Purdue Pharma’s Sackler family owners are offering to increase their financial contribution to a bankruptcy settlement of opioid lawsuits while accepting some exposure to future litigation ...
The Sacklers and Purdue Pharma boosted their settlement contribution to $7.4 billion after the U.S. Supreme Court overturned a prior settlement in June 2024. If approved, the new plan would end ...
Operating within Purdue’s William D. and Sherry L. Young Institute for Advanced Manufacturing of Pharmaceuticals, consortium partners will revolutionize pharmaceutical manufacturing with a focus on ...
Hosted on MSN20d
Purdue Pharma and the Sackler family to pay $7.4 billion in settlement over the toll of OxyContinMembers of the family who own OxyContin maker Purdue Pharma, and the company itself ... note to Dallas fans after blockbuster trade Canada announces retaliatory tariffs on long-time ally US ...
Members of the family who own OxyContin maker Purdue Pharma, and the company itself, agreed to pay up to US$7.4 billion in a new settlement to lawsuits over the toll of the powerful prescription ...
Members of the family who own OxyContin maker Purdue Pharma, and the company itself, agreed to pay up to $7.4 billion in a new settlement to lawsuits over the toll of the powerful prescription ...
FILE - The Purdue Pharma offices are seen, May 8, 2007, in Stamford, Conn. (AP Photo/Douglas Healey, File) FILE - The Purdue Pharma offices are seen, May 8, 2007, in Stamford, Conn. (AP Photo ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback